Although the incidence of infection of the abdominal aortic graft is low, conventional treatment is complex and the outcome can be devastating. The use of synthetic graft alternatives are often not an option for placement directly in an infected field. Conventional treatment methods, such as an extra-anatomical bypass procedure, have been clinically demonstrated to be a costly and clinically inefficient option when compared to the outcomes achieved with cryopreserved arterial allografts. CryoArtery^® Aortoliac allografts provides a safe and effective treatment option for mycotic aneurysms, synthetic graft infections, and aortoenteric fistulas in an infected field.